Methods |
Randomised open controlled study Study location: 2 centres in South Africa Study period: not stated |
Participants |
93 infants < 7 days of life, in room air or requiring 30% oxygen at study entry with birth weight between 900 and 1500 grams Infants were stratified by weight < 1250 grams and > 1250 grams, then were randomised to 3 treatment groups. |
Interventions |
32 infants (low‐dose group) received EPO (Recormon) SC, 250 IU/kg 3 times a week (high dose). 31 infants (high‐dose group) received EPO (Recormon) SC, 400 IU/kg 3 times a week (high dose). 30 infants (control group) received standard care. The endpoint of therapy was reached when the infant was discharged from the hospital. All infants received a therapeutic dose of 6 mg/kg (high dose) elemental iron orally every day; this was increased to 8 to 10 mg/kg (high‐dose iron) if hypochromic cells accounted for 20% or more. All infants subsequently received blood transfusions if they met the transfusion criteria. |
Outcomes |
Use of 1 or more red blood cell transfusions Total volume (mL/kg) of blood transfused per infant Number of blood transfusions per infant Mortality Sepsis Hypertension Length of hospital stay |
Notes |
It is not stated whether infants who had received blood transfusions before study entry were included. Transfusion guidelines were in place. |
Risk of bias |
Bias |
Authors' judgement |
Support for judgement |
Random sequence generation (selection bias) |
Unclear risk |
No information provided |
Allocation concealment (selection bias) |
Unclear risk |
Blinding of randomisation unclear |
Blinding of participants and personnel (performance bias) All outcomes |
High risk |
No placebo was given to the control group. Personnel were aware of treatments. |
Blinding of outcome assessment (detection bias) All outcomes |
High risk |
No placebo was given to the control group. Outcome assessors were aware of treatments. |
Incomplete outcome data (attrition bias) All outcomes |
Low risk |
Complete follow‐up: yes |
Selective reporting (reporting bias) |
Unclear risk |
The protocol for the study was not available to us; therefore we cannot ascertain whether deviations from the protocol occurred. |
Other bias |
Low risk |
Appears free of other bias |